In addition, ClpP became more prominently expressed in metastatic non-small cell lung cancer (NSCLC), compared to non-metastatic lesions, with the highest levels in brain-metastatic NSCLC (Figs 5E, 5F and S5D). This evidence concerns the gene CLPP and non-small cell lung carcinoma.